Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
The study will be conducted in 6 sequential cohorts. Each cohort will enroll 9 participants, randomized to VIS954 or placebo at a ratio of 7:2. On Day 1, a single dose of VIS954 or placebo will be administered SC. Sentinel participants will be utilized in each cohort. After 14 days, the safety data will be evaluated and a decision to admit and dose the next cohort will be made. The total duration of the clinical study per participant will be up to 102 days (approximately 4 months).
Age
18–55
Sex
ALL
Healthy volunteers
Accepted